Roughly 826 million people worldwide have gastroesophageal reflux disease, making it one of the most common digestive conditions on the planet. In the United States alone, an estimated 20% of the population experiences GERD. Those numbers have climbed steeply over the past three decades and show no signs of leveling off.
Global GERD Numbers
In 2021, global GERD prevalence reached approximately 825.6 million cases. To put that in perspective, about 1 in 10 people on Earth deals with this condition at any given time. The number has grown dramatically: in 1990, roughly 451 million people had GERD, meaning cases nearly doubled (an 83% increase) over just three decades. New diagnoses followed a similar trajectory, rising from 180 million incident cases in 1990 to 324 million in 2021.
This growth is driven largely by population expansion and lifestyle changes, particularly rising obesity rates and shifts in diet. Without meaningful changes in prevention and obesity control, prevalence is projected to keep climbing through at least 2040.
How Common GERD Is in the U.S.
The American College of Gastroenterology estimates that up to 20% of the U.S. population has GERD. With a current population of about 340 million, that translates to roughly 68 million Americans. The U.S. falls in line with other Western nations, where rates tend to be considerably higher than in parts of Asia and other regions. Esophageal disorders alone account for more than $18 billion in annual healthcare spending in the country, part of a broader $135.9 billion spent on gastrointestinal diseases overall.
Prevalence Varies by Region
GERD is not evenly distributed around the world. Western countries, including the U.S. and much of Europe, consistently report the highest rates. In contrast, East Asian countries like Japan, China, and South Korea have historically had lower prevalence, though their numbers are rising. Studies from Eastern Asia put the rate at 5% to 8.5% between 2005 and 2010, up from 2.5% to 4.8% before 2005.
Southeast and Western Asia tell a different story. Rates there ranged from 6.3% to 18.3% after 2005, with Turkey reporting prevalence as high as 20%, comparable to Western nations. These regional differences likely reflect a combination of diet, body weight patterns, and genetic factors, though the rapid increases across Asia suggest that lifestyle and dietary westernization play a significant role.
Who Gets GERD Most Often
Age and biological sex are the two strongest independent predictors of GERD. Women are affected at significantly higher rates than men. In one large population study, 64% of GERD cases were in women compared to 27% in men. People with GERD also tend to be older on average, with the mean age of those affected running about five years higher than those without the condition. Both of these associations held up even after adjusting for other variables.
Obesity is another well-established risk factor, and its global rise closely mirrors the upward trend in GERD cases. Excess abdominal weight increases pressure on the stomach and weakens the barrier between the stomach and esophagus, making acid reflux more frequent and more severe.
Why the True Number May Be Higher
The 826 million figure is based on people who meet standard diagnostic criteria, typically defined as heartburn or acid regurgitation occurring two or more days per week. But GERD doesn’t always announce itself with classic symptoms. A form called laryngopharyngeal reflux (sometimes called “silent reflux”) causes throat clearing, hoarseness, and a chronic cough rather than the burning chest sensation most people associate with acid reflux.
Research using specialized pH monitoring found that about 61% of people with laryngopharyngeal reflux had no detectable esophageal reflux at all, meaning they wouldn’t show up in standard GERD testing. Among those patients, nearly 38% tested negative on every conventional GERD measure, including symptom questionnaires, pH probes, and endoscopy. These individuals experience real acid damage but fall through the diagnostic cracks, suggesting the global burden of reflux disease is likely larger than official estimates capture.
Prevalence estimates also vary depending on how studies define the condition. Some require symptoms at least twice a week, others use a lower threshold, and still others rely on endoscopic findings. This inconsistency means that comparing numbers across studies requires some caution, though the overall picture is clear: GERD affects a substantial and growing share of the world’s population.
The Cost of a Common Condition
Because GERD is so widespread, its economic footprint is enormous. In the U.S., patients with erosive esophagitis (a more severe form where stomach acid visibly damages the esophageal lining) face average annual healthcare costs exceeding $58,000 when all causes are included, with about $4,300 of that directly attributable to their esophageal condition. Monthly out-of-pocket pharmacy costs for these patients tend to increase over time as treatments are adjusted, rising from around $37 to $61 per month across successive treatment changes. For a condition affecting tens of millions of Americans, these per-patient costs add up to a staggering collective burden on the healthcare system.